Nanowear Heart Failure Management Multi-sensor Algorithm
NCT: NCT03719079 · TERMINATED
Brief Summary
The NanoSense study is a multi-center, prospective, non-randomized, observational, feasibility, non-significant risk study. The NanoSense study will enroll up to 500 subjects in up to 10 centers in order to collect data which includes at least 150 heart failure hospitalizations in participating subjects.The duration of the NanoSense study is expected to be 2 years. The study device is the Wearable Congestive Heart Failure Management System (WCHFS, also known as SimpleSENSE)
Frequently Asked Questions
What is Nanowear Heart Failure Management Multi-sensor Algorithm?
Nanowear Heart Failure Management Multi-sensor Algorithm is a clinical trial registered under NCT03719079. Current status: TERMINATED.
What is the status of NCT03719079?
The current status of NCT03719079 (Nanowear Heart Failure Management Multi-sensor Algorithm) is: TERMINATED.
When did Nanowear Heart Failure Management Multi-sensor Algorithm start?
Nanowear Heart Failure Management Multi-sensor Algorithm started on 2019-08-21.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.